Clonazepam (Epilepsy) updated on 02-10-2025

Low Apgar score (< 7) (at 1 min)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S5924
R15054
Artama (Epilepsy) (Controls exposed to Lamotrigine, sick), 2013 1-min Apgar <7 3rd trimester population based cohort retrospective exposed to other treatment, sick excluded Adjustment: No 3.22 [0.61;16.96] C
excluded (control group)
2/12   9/154 11 12
ref
S5905
R14846
Artama (Epilepsy) (Controls unexposed, disease free), 2013 1-min Apgar <7 3rd trimester population based cohort retrospective unexposed, disease free excluded Adjustment: Yes 4.75 [1.03;21.98]
excluded (control group)
2/12   27,939/689,482 27,941 12
ref
S5916
R14965
Artama (Epilepsy) (Controls unexposed, sick), 2013 1-min Apgar <7 3rd trimester population based cohort retrospective unexposed, sick Adjustment: Yes 4.49 [0.90;22.39] 2/12   69/1,708 71 12
ref
S8222
R25759
Endo (Epilepsy) (Controls unexposed, disease free), 2004 Apgar score (<8 at 1min) throughout pregnancy retrospective cohort unexposed, disease free excluded Adjustment: No 4.89 [0.10;249.78] C
excluded (control group)
0/1   47/280 47 1
ref
S8224
R25789
Endo (Epilepsy) (Controls unexposed, sick), 2004 Apgar score (<8 at 1min) throughout pregnancy retrospective cohort unexposed, sick Adjustment: No 1.00 [0.00;255.63] C 0/1   0/1 0 1
ref
Total 2 studies 4.00 [0.85;18.71] 71 13
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Artama (Epilepsy) (Controls unexposed, sick), 2013Artama, 2013 1 4.49[0.90; 22.39]711292%ROB confusion: seriousROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Endo (Epilepsy) (Controls unexposed, sick), 2004Endo, 2004 2 1.00[0.00; 255.63]018%ROB confusion: criticalROB selection: unclearROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Total (2 studies) I2 = 0% 4.00[0.85; 18.71]71130.510.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Epilepsy) (Controls unexposed, sick; 2: Epilepsy) (Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 4.00[0.85; 18.71]71130%NAArtama (Epilepsy) (Controls unexposed, sick), 2013 Endo (Epilepsy) (Controls unexposed, sick), 2004 2 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 4.00[0.85; 18.71]71130%NAArtama (Epilepsy) (Controls unexposed, sick), 2013 Endo (Epilepsy) (Controls unexposed, sick), 2004 2 Tags Adjustment   - No  - No 1.00[0.00; 255.63]-1 -NAEndo (Epilepsy) (Controls unexposed, sick), 2004 1   - Yes  - Yes 4.49[0.90; 22.40]7112 -NAArtama (Epilepsy) (Controls unexposed, sick), 2013 1 All studiesAll studies 4.00[0.85; 18.71]71130%NAArtama (Epilepsy) (Controls unexposed, sick), 2013 Endo (Epilepsy) (Controls unexposed, sick), 2004 20.510.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 8222, 5924, 5905

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 4.77[1.15; 19.85]27,988130%NAArtama (Epilepsy) (Controls unexposed, disease free), 2013 Endo (Epilepsy) (Controls unexposed, disease free), 2004 2 unexposed, sick controlsunexposed, sick controls 4.00[0.85; 18.71]71130%NAArtama (Epilepsy) (Controls unexposed, sick), 2013 Endo (Epilepsy) (Controls unexposed, sick), 2004 2 exposed to other treatment, sick controlsexposed to other treatment, sick controls 3.22[0.61; 16.96]1112 -NAArtama (Epilepsy) (Controls exposed to Lamotrigine, sick), 2013 10.510.01.0